Skip to content

Acupuncture for the Post-Stroke depression: a study of a randomized controlled trial

Acupuncture for the Post-Stroke depression: a study of a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000806
Enrollment
Unknown
Registered
2025-04-22
Start date
2025-05-20
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Stroke depression

Interventions

Sponsors

Shenzhen Hospital (Fu Tian) of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) A group of patients who met the definition of ischemic stroke as defined in the International Classification of Diseases Eleventh Edition (ICD-11) and whose depressive manifestations met the diagnostic criteria for depression in the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5); (2) Neuroimaging showing a first ischemic stroke with a disease duration of 1-6 months (recovery period); (3) Right-handedness as assessed by the Edinburgh Handedness Inventory (EHI); (4) Age greater than 18 years and less than 80 years; (5) Hamilton Depression Scale score (HAMD-17) = 8; (6) Not taking any medication related to the treatment of depression/taking a stable dose of depression medication; (7) Consciousness no significant communication difficulties and stable vital signs (as determined by the level of consciousness and language items of the National Instrument for Stroke Scale (NIHSS)); (7) Have not received acupuncture treatment in the previous 6 months.

Exclusion criteria

Exclusion criteria: (1) History of mental disorders drug abuse and addiction immediately prior to stroke; (2) Contraindications to acupuncture such as ulcers abscesses and skin infections at the site of needling; and (3) Patients with severe primary diseases of the circulatory system respiratory system digestive system urinary system endocrine system and hematopoietic system which cannot be controlled by conventional medication; (4) Planned surgery during the trial period. (4) Patients who are scheduled to undergo surgery during the trial; (5) Patients who are claustrophobic or in compliance with the trial. (5) Claustrophobia or other contraindications to functional magnetic resonance; and (6) Participation in other clinical trials within the last month; (7) Inability to give informed consent. (7) Inability to give informed consent; and (8) Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Patient Health Questionnaire - 9 Item Version;Hamilton Depression Scale-17 item;

Secondary

MeasureTime frame
Generalized Anxiety Disorder(GAD-7);Mao Treatment Expectancy Scale;Stroke specific Quality of Life Scale;Stroke Rehabilitation Self Efficacy Scale;Generalized Anxiety Disorder Scale-7;Improved Rankin Scale;national institute of health stroke scale;

Countries

China

Contacts

Public ContactShaoyang Cui

Shenzhen Hospital (Fu Tian) of Guangzhou University of Chinese Medicine

herb107@126.com15112491899

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026